Start:
September 25, 2019
End:
November 2022
Enrollment:
150
This clinical trial will test montelukast, a medication used to treat asthma, on the memory and thinking in people with mild cognitive impairment and early Alzheimer's dementia. Participants will be randomly assigned to take either the study drug or a placebo, starting at 10 mg daily and rising to 20 mg and 40 mg, for one year. Researchers will look at brain imaging, cognitive function, and biomarkers from a lumbar puncture to measure the effect.
Minimum Age: 50 Years
Maximum Age: N/A
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Lead: Emory University
Source: ClinicalTrials.gov ID: NCT03991988
An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health